TVASurg New Video Release – Difficult Laparoscopic Cholecystectomy

The TVASurg team, along with Dr. Shiva Jayaraman from St. Joseph’s Health Centre, is happy to announce the first case launch in 2016. This case focuses on techniques and approaches in dealing with a difficult laparoscopic cholecystectomy, and is one of many cases in an upcoming video series. http://pie.med.utoronto.ca/tvasurg/TVASurg_content/surg/PB_difficultCholecystectomy_subtotal2A.html Stay tuned for more updates in February!   The TVASurg...

ASTS-Astellas Transplantation Grant Awarded to Toronto Tx Fellow, Nicolas Goldaracena

Dr. Nicolas Goldaracena was the recipient of the 2015 ASTS-Astellas Fellowship in Transplantation Grant for his research, “Subnormothermic ex vivo liver perfusion allows graft treatment and modification prior to liver transplantation” (Period: July 1, 2015-June 30, 2017). Read more at ASTS link: http://asts.org/grants-and-research/grants/grant-recipients Dr. Goldaracena’s other recent awards include: American Society of Transplant Surgeons (ASTS) Top Junior Investigator Award (Vanguard Committee). Top Abstracts in the Fellow Category. ASTS 15th Winter Symposium, 2015. “Subnormothermic Ex Vivo Liver Perfusion (SNEVLP) Reduces Endothelial Cell Damage and Bile Duct Injury after Pig Liver Transplantation with HBD Grafts”. Goldaracena N, Spetzler V, Kaths M, Echeverri J, Selzner M. American Society of Transplantation Poster of Distinction Award. “Live vs. Deceased Donor Liver Transplantation Results in Identical Outcome in Recipients with Acute Liver Failure-An Important Choice for Critical Ill Patients”. Goldaracena N, Sapisochin G, Echeverri J, Kaths M, Selzner N, Cattral M, Greig P, Lilly L, McGilvray I, Levy G, Ghanekar A, Renner E, Grant D, Selzner M. Poster presentation at the 2015 American Transplant Congress, Philadelphia, Pennsilvania, US, May 2-6,...

Toronto Tx Fellows Martin Dib and Nicolas Goldaracena present at ASTS 2016 Winter Symposium

Dib MJ, Goldaracena N, Marquez M, Barbas A, Alotaiby N, Sapisochin G, Cattral MS, Lilly L, McGilvray I, Renner E, Greig PD, Ghanekar A, Selzner N, Selzner M, Grant DR.  Impact of ideal body weight vs. actual body weight on the prediction of small-for-size syndrome (SFSS) after living donor liver transplantation (LDLT). Dib MJ, Goldaracena N, Marquez M, Barbas A, Sapisochin G, Selzner N, McGilvray I, Renner E, Greig PD, Lilly L, Ghanekar A, Cattral MS, Selzner M, Grant DR. Long-term outcomes after splenectomy for small-for-size syndrome SFSS in live donor liver transplantation (LDLT). Goldaracena N, Echeverri J, Kaths M, Spetzler V, Selzner N, Grant D, Selzner M. Adding Anti-Inflammatory Agents During Normothermic Ex-Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation. Goldaracena N, Sapisochin G; Dib M, Barbas A, Selzner N, Cattral M S, Greig P D, Lilly L, McGilvray I D,  Levy G A; Ghanekar A, Renner E L; Grant D R,  Selzner M. Live Donor Liver Transplantation With Older Donors Only Impacts on a Late HCV...

Dr. Ghanekar and Team Make Breakthrough Discovery, Turning Stem Cells into Bile Duct Cells

From Stem Cells to Livers Bile ducts are structures in the liver that secrete bile to help with digestion. The ducts are lined with cells called cholangiocytes; when these cells malfunction, liver damage occurs and a transplant is usually needed. Although bile duct disorders are a well-known cause of liver disease, the events that lead to the malfunction of these cells are not fully understood. A team led by Drs. Anand Ghanekar, Gordon Keller, Shinichiro Ogawa and Binita Kamath (SickKids) recently discovered how to turn stem cells into bile duct cells. Equipped with this new method, the team will be able to uncover what leads to cholangiocyte malfunctioning and develop new therapies for liver diseases. Read more at Directed differentiation of cholangiocytes from human pluripotent stem cells. Ogawa M, Ogawa S, Bear CE, Ahmadi S, Chin S, Li B, Grompe M, Keller G, Kamath BM, Ghanekar A. Nature Biotechnology 2015 Aug;33(8):853-61.  ...